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Abstract
Background: Resveratrol has been reported as a natural phytoalexin that inhibits infection or the growth of certain
fungi including Aspergillus flavus. Our previous research revealed that aflatoxin production in A. flavus was reduced
in medium with resveratrol. To understand the molecular mechanism of the A. flavus response to resveratrol
treatment, the high-throughput paired-end RNA-Seq was applied to analyze the transcriptomic profiles of A. flavus.
Results: In total, 366 and 87 genes of A. flavus were significantly up- and down- regulated, respectively, when the
fungus was treated with resveratrol. Gene Ontology (GO) functional enrichment analysis revealed that 48 significantly
differentially expressed genes were involved in 6 different terms. Most genes in the aflatoxin biosynthetic pathway
genes cluster (#54) did not show a significant change when A. flavus was treated with resveratrol, but 23 of the 30
genes in the #54 cluster were down-regulated. The transcription of aflA and aflB was significantly suppressed under
resveratrol treatment, resulting in an insufficient amount of the starter unit hexanoate for aflatoxin biosynthesis. In
addition, resveratrol significantly increased the activity of antioxidative enzymes that destroy radicals, leading to
decreased aflatoxin production. Moreover, stuA, fluG, flbC, and others genes involved in mycelial and conidial
development were down-regulated, which disrupted the cell’s orderly differentiation and blocked conidia formation
and mycelia development. The transcripts of laeA and veA were slightly inhibited by resveratrol, which may partly
decrease aflatoxin production and depress conidia formation.
Conclusions: Resveratrol can affect the expression of A. flavus genes that are related to developmental and secondary
metabolic processes, resulting in decreased aflatoxin production and conidia formation and could also cause abnormal
mycelia development. These results provide insight into the transcriptome of A. flavus in response to resveratrol and a
new clew for further study in regulation of aflatoxin biosynthesis in A. flavus.
Background
The widespread fungus Aspergillus flavus is a sapro-
phytic and opportunistic pathogen that is capable of
causing diseases in agricultural crops [1], producing
toxic secondary metabolites, and bringing about health
problems in animals and humans [2]. Under favorable
conditions, A. flavus produces polyketide-derived carcino-
genic and mutagenic secondary metabolites, aflatoxins [3],
which are extremely hepatotoxic, immunosuppressive,
and antinutritional mycotoxins associated with both acute
and chronic toxicity in humans and animals [4]. Besides the
health implications in humans and animals, A. flavus
colonization in crops causes considerable economic losses
because of reduced utilization and lower price of aflatoxin-
contaminated grains.
To develop effective means of combating aflatoxin
contamination, it is of vital importance to investigate the
molecular mechanisms of development and secondary
metabolism in A. flavus. Previous studies identified nu-
merous diverse biochemical substances and extracts with
adverse effects on the development and/or secondary
metabolism of A. flavus [5–10]. Resveratrol (3,5,4-trihy-
droxystilbene) is a phytoalexin with antifungal activity
and antioxidant capacity, which can enhance host plant
resistance against biotic and abiotic stresses [11]. Our
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previous study found that resveratrol is highly related to
resistance to aflatoxin production in peanut seeds and
could inhibit aflatoxin production in medium [12]. In
addition, resveratrol affected mycelial morphologic char-
acteristics and inhibited conidia formation of A. flavus in
medium. However, how resveratrol affects the develop-
ment and secondary metabolism of A. flavus remains
unknown.
RNA-sequencing (RNA-seq) is a powerful and cost-
efficient high-throughput technology for transcriptomic
profiling analysis that has been successfully used to in-
terrogate transcriptomes of numerous fungi [10, 13–17].
The application of this technology has greatly acceler-
ated our understanding of the complexity of gene ex-
pression, regulation, and networks [18]. Gene expression
can be more accurately quantified using RNA-seq ap-
proaches than conventional transcriptomic analysis [18].
With higher sensitivity, RNA-seq can also be more
efficient in detecting a larger range of dynamically
expressed genes than microarrays. Furthermore, RNA-
seq has been used to survey sequence variations and
complex transcriptomes with low false-positive rates
and high sensitivity and reproducibility [14, 19]. For an
organism with a well-annotated genome, mapping read
sequences to the corresponding reference genome/tran-
scriptome is usually the first and essential step for
RNA-seq data analysis [10]. Moreover, the “reference-
based” RNA-seq approach was proved to be more sen-
sitive and have higher computational efficiency than a
de novo assembly approach [20]. The construction of
expressed sequences tags in A. flavus was reported by
several researchers [21], and the whole-genome sequen-
cing of the fungus was completed [22]. Annotation of
the A. flavus genome revealed numerous genes and
gene clusters that are potentially involved in conidia
formation and secondary metabolic processes including
aflatoxin biosynthesis [23, 24]. The transcriptomic ana-
lysis of aflatoxin biosynthesis and mycelia development
in A. flavus in response to 5-azacytidine [10, 25], de-
canal [17], water activity [26], and temperature [27] also
used RNA-seq technology.
To comprehensively understand the effect of resver-
atrol on the development and secondary metabolism
of A. flavus, an RNA-seq approach was applied in this
study to obtain transcriptomic profiles of A. flavus at
the whole-genome level. Differentially expressed genes
(DEGs) associated with mycelial growth, conidia for-
mation, and aflatoxin biosynthesis were revealed by
comparing resveratrol-treated and untreated samples
of A. flavus. This study would be meaningful for fur-
ther annotating the genome of A. flavus, an under-
standing of aflatoxin biosynthesis and improving
aflatoxin contamination management in agricultural
products.
Results
Effect of resveratrol on the development and aflatoxin
production of A. flavus
Morphological characteristics and aflatoxin concentra-
tions were quantified to define the effect of resveratrol
on the fungal development and toxigenicity of A. flavus.
The dry biomass of A. flavus mycelia grown in liquid
A&M medium did not show significant difference be-
tween the resveratrol treatment (AM-Res) and the con-
trol (AM) (Table 1). A similar result was obtained using
solid A&M medium, in which resveratrol treatment did
not significantly change the diameter of fungal mycelioid
colonies (Fig. 1 and Table 1). However, obvious variation
in morphological characteristics of mycelia in response
to resveratrol treatment in shaking liquid culture was
observed (Fig. 2). The vegetative mycelial morphologic
characteristics of A. flavus were different between the
AM and the AM-Res cultures, and the vegetative mycelia
of A. flavus appeared some smaller ones in the AM-Res.
Resveratrol may affect the germination rate of conidia or
growth rate of vegetative mycelia, leading to differences in
the length of the mycelia. The results indicated that res-
veratrol did not affect the biomass accumulation of A.
flavus, but it could influence the development of fungal
mycelia.
Because no fungal conidium was detected in liquid
culture, solid A&M medium was used to investigate the
effect of resveratrol on conidia production by A. flavus.
The number of conidia was 285.31 × 106 and 175.21 ×
106 per 20 mL medium in the control and resveratrol
treatment (3.0 μg/mL), respectively (Fig. 1 and Table 1).
In addition, the number of conidia was 197.83 × 106,
180.83 × 106, 163.06 × 106, and 164.17 × 106 per 20 mL
medium with resveratrol at concentrations of 0.3, 15.0,
30.0, and 60.0 μg/mL, respectively. Conidia formation of
A. flavus was decreased in the resveratrol treatment
compared with the control.
Table 1 Effect of resveratrol on the development and aflatoxin production of A. flavus
Mycelia biomass AF production Mycelioid colony diameter Conidia number
(g/60 mL) (μg/L) (cm) (1 × 106 CFU/20 mL)
AM (Control) 0.411 ± 0.027 385.49 ± 17.38 7.1 ± 0.27 285.31 ± 52.50
AM-Res (Treatment) 0.464 ± 0.0067 203.55 ± 31.46 * 7.6 ± 0.35 175.21 ± 40.17 *
Note: AM-Res (Treatment) and AM (Control) indicate that A. flavus was cultured in A&M medium with or without resveratrol, respectively. * denotes significant dif-
ferences (p < 0.05) between mean values of AM-Res and AM by a t-test
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The aflatoxin concentration was measured after 7 days
of growth in liquid culture. The aflatoxin content in the
resveratrol-treated culture (3.0 μg/mL) was 203.6 μg/L,
which was much less than that in the control (Table 1),
indicating that resveratrol inhibited aflatoxin formation.
Our previous results also indicated that a resveratrol
concentration of 3.0 μg/mL or higher inhibited aflatoxin
production [12].
Defining the A. flavus transcriptome
Illumina sequencing of the resveratrol-treated and un-
treated A. flavus AF2202 generated 52.06 million and
52.72 million raw reads per library, respectively. Among
total reads, approximately 51 million reads were purified
from each group (Fig. 3), which included 46.00 million
(89.42 %, AM-Res) and 45.34 million (89.68 %, AM)
reads that were uniquely mapped to the A. flavus refer-
ence genome (Additional file 1). The data sets could rep-
resent the expressed sequences or transcriptomes of
each library. Matching the reads to genes is important to
annotate sequences because it could reveal the molecu-
lar mechanism behind gene expression [28]. Thus, tran-
scriptomic data obtained in this experiment were used
not only to define the differential gene expression in re-
sponse to resveratrol but also to identify hitherto un-
known transcripts including putative isoforms. The
genic distribution of reads from mRNA-seq of the
resveratrol-treated AF2202 (AM-Res) indicated that
most reads (88.0 %) were mapped to protein-coding
genes. The others were distributed between introns
(0.7 %) and intergenic regions (11.3 %) (Fig. 4). The dis-
tribution of reads in the control AF2202 (AM) was simi-
lar to that of the resveratrol-treated (AM-Res), but fewer
reads in the control were mapped to exons (Fig. 4). In
total, 10.2 Gb of valid clean reads were yielded, and
98.82 % (9.13 Gb) of the 9.24 Gb of collected read pairs
that passed filtering were mapped uniquely to the gen-
ome (Additional file 1), which was higher than the RNA-
AM AM-Res
Fig. 1 Mycelioid colony of A. flavus cultured on solid A & M medium. AM (Control), resveratrol was not added to the A&M medium. AM-Res (Treat-
ment), resveratrol was added to the A&M medium (3.0 μg/mL). The mycelioid colony diameter of A. flavus in the AM-Res was similar to that in the AM,
but the number of A. flavus conidia in the AM was greater than that in the AM-Res
AM AM-Res 
Fig. 2 Vegetative mycelia of A. flavus cultured in liquid A & M medium. AM (Control), resveratrol was not added to the A&M medium. AM-Res
(Treatment), resveratol was added to the A&M medium (3.0 μg/mL)
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seq data published previously for A. flavus [10, 26, 27]
and A. oryzae [13].
In 2005, a 5× sequence coverage of the A. flavus gen-
ome was released by J. Craig Venter Research Institute,
which has been recently updated at several web sites
(http://www.aspergillusflavus.org/genomics/, NCBI). The
A. flavus genome is about 37 Mb on 8 chromosomes,
and it encodes over 13,487 functional genes (Aspergillus
flavus Genome Sequencing Project), which previously
were annotated as open reading frames in the genome
without unambiguous transcript information. We quan-
tified the overall transcriptional activity of genes in this
study by calculating the number of reads per kilobase of
exon per million mapped reads (RPKM) [29]. We found
that 9,870 (71.14 %) of the 13,875 genes (http://fungi.en-
sembl.org/Aspergillus_flavus/Info/Annotation/#assembly)
in the A. flavus genome database had expression with
RPKM ≥ 1 in either of the two samples (Additional
files 2 and 3).
AM
Clean Reads 50561156(97.12%) Containing N 59738(0.11%)
Low Quality 1350024(2.59%) Adapter Related 88054(0.17%)
AM-Res
Clean Reads 51441686(97.57%) Containing N 53862(0.10%)
Low Quality 1132886(2.15%) Adapter Related 95008(0.18%)
Fig. 3 Classification of raw reads. Raw reads including clean reads
(blue), adapter sequences (purple), reads containing undefined
















Fig. 4 Distribution of reads mapped to genome regions. The genic
distribution of reads from mRNA-seq of A. flavus (AF2202) mapped
to exons (blue), introns (red), and intergenic regions (green)
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Besides the small fraction of reads that mapped to
rRNA, approximately 11 % of reads could not be
mapped to the encoding regions. This might be due to
non-coding RNAs or novel exons of known genes. Novel
genes were identified by assembling the RNA-seq data
from the two samples using Cufflinks 2.1.1 [30]. Among
the 14,592 annotated genes expressed in the two sam-
ples, 13,875 were previously annotated genes and 717
were novel genes (Additional file 4). According to the
improved genome annotation, the transcriptional activity
of the genes was estimated.
Functional classification of A. flavus DEGs in response to
resveratrol
The differently expressed genes between the two librar-
ies provide a clue to the molecular mechanism related to
the A. flavus response to resveratrol. By comparing ex-
pression levels in resveratrol-treated and untreated sam-
ples, we identified 453 genes that were significantly
differentially transcribed (log2[fold change] = log2[AM-
Res/AM] > 1, q value < 0.005) between the two samples,
including 22 genes (4.86 % of the DEGs) showing a 10-
fold change (Additional file 5). Of these, 366 genes
(80.79 %) were up-regulated and 87 (19.21 %) genes were
down-regulated. Genes with altered expression were re-
lated to a wide variety of regulatory and metabolic
processes.
Functional assignments were defined by Gene Ontol-
ogy (GO) terms (http://www.genontology.org/), which
provided a broad functional classification of genes and
gene products for various biological processes, molecu-
lar functions, and cellular localizations. GO functional
enrichment analysis revealed that these significantly
DEGs were mainly involved in fatty acid metabolic
process, monocarboxylic acid metabolic process, signal-
ing receptor activity, phosphorelay sensor kinase activity,
protein histidine kinase activity, and phosphotransferase
activity (nitrogenous group as acceptor) (q value < 0.05)
(Table 2 and Additional file 6). As mentioned above, A.
flavus and other Aspergilli preferentially colonize crop
seeds with a high oil content because these crops con-
tain high levels of unsaturated fatty acids, linoleic (18:2)
and oleic acid (18:1), which are substrates for oxygenases
[31, 32]. Oxylipins, derived from oxygenases, are a class
of oxygenated, unsaturated fatty acids involved in signal-
ing pathways in filamentous fungi, yeasts, oomycetes,
plants, and animals [33]. A family of oxylipin-producing
oxygenases and their products, which is encoded by ppo
(fungi) and lox (plants, animals, and fungi), are involved
in regulating sclerotia and conidia formation and sec-
ondary metabolism in A. flavus, A. nidulans, and A.
parasiticus [5, 34]. Oxylipins could potentially interact
with G-protein-coupled receptor complexes upstream of
the heterotrimeric G-protein complex that regulates af-
latoxin/sterigmatocystin production [35, 36]. More-
over, the transcription of genes of fatty acid synthases
(AFLA_139380 and AFLA_139370), the key genes in
the aflatoxin biosynthetic pathway cluster, was signifi-
cantly down-regulated when A. flavus was treated with
resveratrol.
To further investigate the biological functions and in-
teractions of genes, pathway-based analysis was con-
ducted using the Kyoto Encyclopedia of Genes and
Genomes (KEGG, http://www.genome.ad.jp/kegg) path-
way database, which records the network of molecular
interactions in the cells and variants specific to particu-
lar organisms. However, KEGG metabolic pathway ana-
lysis failed to confirm enrichment in any pathway in the
RNA-seq data (q value < 0.05) obtained in this study,
which is consistent with results of a previous study by
Lin [10].
Validation of RNA-seq analysis by quantitative real-time
PCR (qRT-PCR)
It is common practice to validate RNA-seq differential
analysis with quantitative analysis of a subset of genes by
qRT-PCR. Thus, we compared qRT-PCR expression levels
of 16 DEGs randomly selected from the resveratrol-
treated and untreated A. flavus samples (Table 3). Gene-
specific primer pairs (Table 3) were designed according to
Table 2 Gene Ontology (GO) functional enrichment analysis of differentially expressed genes when A. flavus was treated with
resveratrol
GO ID Term name Name space p value q value DEG DEG
list item
GO:0006631 Fatty acid metabolic process Biological process 1.19E-05 0.02473 11 257
GO:0032787 Monocarboxylic acid metabolic process Biological process 2.52E-05 0.02473 12 257
GO:0038023 signaling receptor activity Molecular function 2.77E-05 0.02473 7 257
GO:0000155 Phosphorelay sensor kinase activity Molecular function 3.70E-05 0.02473 6 257
GO:0004673 Protein histidine kinase activity Molecular function 3.70E-05 0.02473 6 257
GO:0016775 Phosphotransferase activity (nitrogenous group as acceptor) Molecular function 3.70E-05 0.02473 6 257
q value: Corrected p value; DEG list: the number of GO-annotated differently expressed genes; DEG item: the number of differently expressed genes associated
with the GO term
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the 16 genes’ sequences using the online Primer 3-BLAST
program (bioinfo.ut.ee/primer3-0.4.0/primer3/, NCBI).
The qRT-PCR data mirrored the quantification by RNA-
seq (Fig. 5), with a significant correlation (R2 = 0.936), in-
dicating the authenticity of these DEGs. Thus, these com-
parisons of data from qRT-PCR and RNA-seq of strain
AF2202 not only validated the transcriptome analysis, but
also reinforced the power of next-generation sequencing
in quantifying the entire repertoire of genes.
Gene expression of the secondary metabolism gene
clusters in response to resveratrol
The A. flavus genome sequence contains hallmark en-
zymatic genes associated with secondary metabolite syn-
thesis, including 55 putative secondary metabolism gene
clusters [24, 37, 38]. Each secondary metabolism gene
cluster contains enzymatic genes and transcription factors
for compound synthesis [39]. To evaluate the effect of res-
veratrol on the regulation of secondary metabolism, we
Table 3 Primer pairs for each target gene for quantitative real-time PCR
Gene Name Primer sequence (5′-3′) Product size Annealing
temperature (°C)(bp)
Up-regulated
AFLA_125090 AGGTTGTTCTCGGTCTGGTT 137 65
GCAAGGTCACCTACATGCAC
AFLA_075280 AGCTGGTTCGGTTTACCATC 128 64.5
ATGGCGATAGGGACAGGTAG
AFLA_057960 TGCAGACCAATGTTCATCCT 108 64.5
GTTGTCTCAGTCGTGCCAGT
AFLA_039390 CGCAACAAAGCAAGACATTT 128 61.4
GTCGGAGGGCTTGATTGTAT
AFLA_077590 CGTCGATTATGATGGAGACG 65 58.9
CACTGCTCAGCATTCCGTAT
AFLA_021650 GTTGGGCTATACGGAGGTGT 137 58.9
GCCATAGAGCAGCCAGTACA
AFLA_075300 GTGATTCATAGGGCCGACTT 156 64.5
GACGACAAGGTCTCCGGTAT
AFLA_023780 CTCCTCGACCGATTACCATT 125 57.1
CCCACTAACCACATCGACAG
Down-regulated
AFLA_117290 TTGCCCTCTGTTGAAGACTG 92 65
CCTCGTAGGACTTCCTCAGC
AFLA_112010 CAGTCGAACCCTATCCACCT 145 58.9
TACGTTCGGAGACACGGATA
AFLA_137320 AGCTACCCAGCACCAGAAGT 76 58.9
TGTAGGCAGGAGTCTGTTCG
AFLA_117420 CGGCAGAAGAGTACTGGTGA 106 57.1
ACGACTGGTGGTGACGATAA
AFLA_117340 TACAACCGGCTACAGCTCAC 113 57.1
TGATCGACTCGGAAAGACTG
AFLA_058990 ACGAGTCCTACCACCAGTCC 64 55
TTGATGGTTCCTCCTCCTTC
AFLA_128370 CCCTCTTTGGTAAGAATCGC 144 55.8
CGTCGGCCATATTCACATAG
AFLA_129450 GTACAGCCGTGGGATTCTTT 112 55.8
TGGAGCCAGTAGATATTGCG
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used the information from the web-based software Sec-
ondary Metabolite Unknown Regions Finder (SMURF,
http://www.jcvi.org/smurf) to identify the putative sec-
ondary metabolism gene clusters of A. flavus. Among the
55 clusters in the A. flavus genome, the expression levels
of most clusters were not significantly affected by resvera-
trol (Additional file 7). By comparing the expression levels
of secondary metabolic genes in resveratrol-treated and
untreated samples, we identified 17 genes (2.45 % of 695
secondary metabolic genes) in 13 secondary metabol-
ism gene clusters that were significantly differentially
transcribed (log2[fold change] = log2[AM-Res/AM] > 1,
q value < 0.005), with 2 backbone genes (AFLA_004450
and AFLA_118440) (Additional file 7). The backbone
genes included a non-ribosomal peptide synthase (NRPS,
AFLA_004450), which is an enzyme that produces a poly-
peptide independent of ribosomes, and an NRPS-like syn-
thase (AFLA_118440), which was named because it does
not contain all of the typical domains normally found in
an NRPS [2].
In the aflatoxin biosynthetic pathway cluster, 30
genes were identified as cluster #54 [2]. In this study,
the transcription of 23 of the 30 genes was depressed
to various degrees with resveratrol treatment, and
only 7 genes (AFLA_139460, AFLA_139450, AFLA_139390,
AFLA_139260, AFLA_139330, AFLA_139220, and
AFLA_139210) were not down-regulated (Additional
file 7). Interestingly, aflA (AFLA_139380) and aflB
(AFLA_139370) were significantly down-regulated (q
value < 0.005). aflA and aflB encode the fatty acid syn-
thetase alpha subunit (Fas-2) and beta subunit (Fas-1),
respectively, which catalyze the reaction between
acetyl-CoA and malonyl-CoA to form the starter unit
hexanoate of aflatoxin biosynthesis [40, 41]. However,
the transcription regulator genes aflR (AFLA_139360)
and aflS (AFLA_139340) in the cluster showed only
medium or slight down-regulation (Additional file 7), and
the transcription of the global secondary metabolite
regulators laeA (AFLA_033290) and veA (AFLA_066460)
did not show significant depression (Table 4). More-
over, the expression of three genes (AFLA_139500,
AFLA_139240, and AFLA_139230) was too low in the
control sample to be distinguished by HTSeq (v0.5.3p9).
In cluster #2, only the backbone gene AFLA_004450,
encoding a dimethylallyl transferase (DMAT, an indole-
alkaloids) enzyme, had significantly down-regulated tran-
scription (q value < 0.005), but the transcription of the
other 9 genes in this cluster was not significantly different
when resveratrol was applied (Additional file 7). Also, in
cluster #44, which has an unknown product, only the
backbone gene AFLA_118440, encoding a polyketide syn-
thetase (PKS) enzyme, was significantly up-regulated with
resveratrol treatment (q value < 0.005) (Additional file 7).
A total of 6 genes in cluster #9 (AFLA_017860 and
AFLA_017820), #24 (AFLA_069370 and AFLA_069340),
and #41 (AFLA_116250 and AFLA_116240) showed sig-
nificant differential transcription (q value < 0.005) with
resveratrol treatment. The products of these three clusters
are unknown, but their backbone enzymes were predicted
by SMURF. The backbone enzyme of cluster #9 is an
NRPS-like enzyme, which is encoded by AFLA_017840.
The backbone gene AFLA_069330 of cluster #24 encodes
the NRPS Pes1, and the backbone enzyme of cluster #41
is a PKS. Genes in the other secondary metabolism gene
clusters did not show significantly altered expression when
resveratrol was applied. Only a few genes, such as
AFLA_008690 in cluster #6, AFLA_054050 in cluster #16,
AFLA_059950 in cluster #18, AFLA_060690 in cluster
#19, AFLA_070820 in cluster #25, AFLA_084160 in clus-
ter #30, and AFLA_108440 in cluster #37, were signifi-
cantly affected (q value < 0.005) (Additional file 7).
Expression analysis of A. flavus growth- and conidial
development-related genes in response to resveratrol
Using the expression profiles of A. flavus in different
treatments, especially the 453 genes that were signifi-
cantly differentially transcribed (Additional file 5), we
observed that some genes involved in mycelial and conidial
development were down-regulated when resveratrol was
applied (Table 4). Noticeably, the transcription of the so-
called fluffy gene family (AFLA_101920, AFLA_137320,
AFLA_134030, AFLA_131490, and AFLA_017380), whose
null mutants have a fluffy or floccose phenotype [25], was
down-regulated to various degrees (Table 4). fluG
(AFLA_101920) and flbC (AFLA_137320) showed signifi-
cantly depressed transcriptional levels (q value < 0.005)
when A. flavus was treated with resveratrol. fluG encodes
an extracellular development signal protein, which may
function as a GSI-related enzyme in the synthesis of a
small diffusible factor that acts as an extracellular signal
directing asexual sporulation and other aspects of colony
growth in A. nidulans [42]. flbC encodes a zinc finger






























Fig. 5 Quantitative real-time PCR validations of the up-regulated
and down-regulated genes characterized by RNA-seq. log2(fold
change) = log2(AM-Res/AM)
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protein (FlbC) that is required for morphogenesis and
the elongation of flagellar filaments by facilitating
polymerization of the flagellin monomers at the tip of
a growing filament in Escherichia coli [43]. Concur-
rently, some conidia-specific genes (AFLA_098380 and
AFLA_014260) were down-regulated slightly (Table 4).
The molecular action of conidial hydrophobins RodA/
RolA (AFLA_098380) and RodB/HypB (AFLA_014260)
contributed to the structural integrity of the cell wall [44,
45]. In addition, the transcription of genes related to
conidial development, such as BrlA (AFLA_082850),
AbaA (AFLA_029620), wetA (AFLA_052030), stuA
(AFLA_046990), GpaA/FadA (AFLA_018340), and
Medusa (AFLA_136410), was decreased to a certain
extent (Table 4). Interestingly, transcription of the stuA
gene (AFLA_046990), which encodes the APSES tran-
scription factor StuA that affects the orderly differenti-
ation and spatial organization of cell types of the
conidiospore, was significantly decreased (the RPKM value
decreased from 173.07 to 79.00, q value < 0.005) [46].
We also found that the transcription of the gene
AFLA_099000 was significantly increased. In A. ory-
zae, AFLA_099000 encodes a superoxide dismutase
[Cu-Zn] that destroys radicals within the cells and is
toxic to biological systems (Table 4). Interestingly, the
transcription of genes involved in vacuolar proteins,
such as AFLA_027560, AFLA_017730, AFLA_039470,
AFLA_060890, AFLA_130130, and Novel 100107, was
significantly increased (Table 4). The vacuolar proteins
may take advantage of the exchange of atmosphere and
nutrients between the organism and the environment.
Nonribosomal peptide synthetase (NRPS) is a key factor
responsible for the biosynthesis of bioactive metabolites
that potentially contribute to organismal virulence; NRPS
is encoded by AFLA_004450, which was significantly
down-regulated (Table 4).
Table 4 Differentially expressed genes related to the development and conidial formation of A. flavus
Gene ID Gene Name RPKM Log2(AM-
Res/AM)
q value DEGs Annotated gene function
AM AM-Res
CADAFLAG00011929 AFLA_101920 4.6010 1.5649 −1.5559 1.249E-88 Yes Extracellular developmental signal biosynthesis protein FluG
CADAFLAG00007028 AFLA_131490 76.2979 53.7967 −0.5041 Hypothetical protein
CADAFLAG00007282 AFLA_134030 7.7607 3.5087 −1.1452 Developmental regulator FlbA development.
CADAFLAG00007610 AFLA_137320 64.9838 16.8385 −1.9483 2.173E-07 Yes C2H2 conidiation transcription factor FlbC
CADAFLAG00003623 AFLA_017380 67.9510 41.5711 −0.7089 Hypothetical protein
CADAFLAG00011576 AFLA_098380 0.4394 0.4080 −0.1068 Conidial hydrophobin RodA/RolA
CADAFLAG00003311 AFLA_014260 0.0000 0.2077 _ Conidial hydrophobin RodB/HypB
CADAFLAG00003719 AFLA_018340 74.9734 43.1293 −0.7977 G-protein complex alpha subunit GpaA/FadA
CADAFLAG00006026 AFLA_046990 173.0674 78.9994 −1.1314 1.435E-55 Yes APSES transcription factor StuA (stunted)
CADAFLAG00007519 AFLA_136410 142.1301 101.1580 −0.4906 Transcriptional regulator Medusa(medusa)
CADAFLAG00001065 AFLA_082850 0.9080 0.4216 −1.1068 C2H2 type conidiation transcription factor BrlA
CADAFLAG00002337 AFLA_029620 1.5396 0.2376 −2.6962 Transcription factor AbaA
CADAFLAG00011194 AFLA_052030 11.7189 5.8671 −0.9981 Regulatory protein wetA
CADAFLAG00006026 AFLA_046990 173.0674 78.9994 −1.1314 Cell pattern formation-associated protein stuA
CADAFLAG00002704 AFLA_033290 27.7370 19.7674 −0.4887 7.824E-10 Regulator of secondary metabolism LaeA
CADAFLAG00008070 AFLA_066460 16.3529 13.0959 −0.3204 1.54E-32 Developmental regulator AflYf / VeA
CADAFLAG00000929 AFLA_081490 33.9585 43.1005 0.3439 Nucleoside diphosphatase Gda1/VelB
CADAFLAG00002131 AFLA_027560 22.5485 37.5174 1.2854 1.77E-07 Yes Vacuolar protein sorting-associated protein 13
CADAFLAG00003658 AFLA_017730 24.5015 41.4414 1.3091 0.0002471 Yes Regulator of V-ATPase in vacuolar membrane protein 1
CADAFLAG00005274 AFLA_039470 27.8848 75.9818 1.9970 1.34E-11 Yes Vacuolar calcium ion transporter
CADAFLAG00006698 AFLA_060890 137.9586 260.6940 1.4690 5.93E-15 Yes Vacuolar amino acid transporter 3
CADAFLAG00010071 AFLA_130130 166.9408 312.7826 1.4567 6.59E-09 Yes Putative vacuolar protein sorting-associated protein TDA6
Novel00107 Novel00107 32.5194 66.4116 1.5810 0.0032328 Yes Vacuolar protein sorting-associated protein 13
CADAFLAG00011638 AFLA_099000 317.3651 906.9007 2.0657 1.19E-49 Yes Superoxide dismutase [Cu-Zn]
CADAFLAG00010511 AFLA_004450 5.3195 1.3098 −1.4711 6.84E-09 Yes Nonribosomal peptide synthetase 12
RPKM: Reads per kilobase per million reads; q value: corrected p value; DEGs: differently expressed genes; AM-Res (Treatment) and AM (Control): A. flavus was
cultured in A&M medium with or without resveratrol, respectively; log2(fold_change) = log2(AM-Res/AM); log2(fold_change) > 0: the expression of a gene was
up-regulated; log2(fold_change) < 0: the expression of a gene was down-regulated
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Discussion
Considerable progress has been achieved in reducing af-
latoxin contamination in agricultural products [47–52]
since the discovery that aflatoxin is extremely toxic to
humans and animals [2, 53]. Many inhibitors [9, 54]
have been demonstrated to have an inhibitory effect on
aflatoxin biosynthesis in A. flavus. Among them, plant-
derived metabolites are of special interest. Non-host
plant metabolites, such as onion, garlic extracts, eugenol
[55–57], khellin, visnagin [58], caffeine, and piperlongu-
mine [59] inhibit A. flavus growth and/or aflatoxin pro-
duction. At the same time, host plant-derived
metabolites including luteolin [60], eriodictyol [61], and
tanning acids [62] also inhibit A. flavus development
and/or aflatoxin production. However, most of these
compounds can hardly be applied in practice because
their biosynthesis pathway and the related biochemical
steps are not well understood.
Resveratrol, a natural phytoalexin, could protect plants
from fungal infection and improve the defense capacity
in plants [63]. Some studies indicated that phytoalexins
play an important role in resistance to aflatoxin contam-
ination in peanut under drought stress [64], and the iso-
flavone phytoalexin glyceollin from soybean could
inhibit aflatoxin production [65]. Field experiments dem-
onstrated that a correlation existed between increased
phytoalexins and decreased aflatoxin B1 [66]. The results
from our previous experiments demonstrated that the
resveratrol level was a factor that was relevant to afla-
toxin resistance in peanut [12]. Resveratrol could affect
A. flavus development and inhibit conidia formation and
aflatoxin production. Moreover, the resveratrol biosyn-
thetic pathway is well known [67]. Thus, it is possible to
enhance resveratrol biosynthesis and concentration by
breeding or genetic engineering, which may provide an
applicable means for aflatoxin contamination manage-
ment. Some transgenic studies indicated that resveratrol
could inhibit other pathogenic fungi [68, 69]. In addition,
resveratrol has been suggested to have a beneficial effect
on human health [70, 71]. Genetic improvement for an in-
creased resveratrol content in crops could not only ensure
food safety, but also enhance the nutritional value of agri-
cultural products.
Aflatoxins are polyketide-derived difurano cumarins,
their biosynthesis involves at least 18 enzymatic reac-
tions [72, 73]. The first step in the biosynthesis requires
the formation of the starter unit hexanoate from acetyl-
CoA and malonyl-CoA catalyzed by Fas-1 and Fas-2 [40,
41], which is then catalyzed by PksA, a polyketide syn-
thase encoded by aflC, to produce norsolorinic acid
anthrone (NAA). The monooxygenase HypC oxidizes
the intermediate NAA to form anthraquinone norsolori-
nic acid, which is the first stable intermediate in afla-
toxin biosynthesis [74, 75]. In this study, we found that
aflA (Fas-2) and aflB (Fas-1) in the aflatoxin biosyn-
thesis pathway cluster were significantly down-regulated
when A. flavus was treated with resveratrol. Aflatoxin is
a highly oxygenated product, and oxidative stress is a
prerequisite for aflatoxin production [76]. Resveratrol-
inhibited aflatoxin biosynthesis also has antioxidant
activity. Superoxide dismutase [Cu-Zn] (AFLA_099000)
(Table 4) had a significantly increased expression level
when resveratrol was added to medium; it destroyed radi-
cals that were normally produced within the cells and
were toxic to biological systems. Superoxide dismutases
inhibit free radical scavenging and protect calcineurin (a
Ca2+/calmodulin-dependent protein phosphatase) from
inactivation [77]. The activity of calcineurin was enhanced
at periods corresponding to aflatoxin production, and afla-
toxin itself can inhibit calmodulin kinase activity [78]. Cal-
modulin also activated acetyl-CoA carboxylase, a key
enzyme in aflatoxin biosynthesis [79]. The transcription of
genes involved in vacuolar proteins significantly increased
(Table 4); these proteins may be involved in the exchange
of atmosphere and nutrients between the organism and
the environment. Moreover, 23 of the 30 genes in the afla-
toxin metabolic cluster had depressed transcription levels.
These observations suggested that resveratrol directly in-
hibits the expression of the aflatoxin pathway cluster
genes aflA and aflB, which could significantly suppress
the formation of the starter unit (hexanoate) of aflatoxin
biosynthesis. In addition, resveratrol highly increased the
activity of antioxidative enzymes to limit aflatoxin produc-
tion. There was also a certain amount of aflatoxin pro-
duced by A. flavus treated with resveratrol because
aflatoxin biosynthesis was only partially inhibited rather
than completely suppressed.
Based on our experimental data, resveratrol could in-
fluence the mycelia development and conidia formation
of A. flavus (Figs. 1 and 2, Table 1), as well as several
other biochemical substances previously reported [10,
80, 81]. Additionally, we have found that some genes in-
volved in mycelial and conidial development were down-
regulated when A. flavus was treated with resveratrol
(Table 4). The changes in mycelia (the morphological
characteristics of mycelia in liquid medium and the
myceloid colony on solid medium) was affected by res-
veratrol, which may be related to the low-level expres-
sion of the so-called fluffy gene family. The formation of
conidia, the asexual reproductive structure, in A. flavus
requires the concerted activity of a number of signaling
proteins and transcription factors [25]. Transcription of
the conidia-specific genes RodA/RolA and RodB/HypB
was down-regulated slightly when resveratrol was ap-
plied (Table 4), but the transcription of some genes re-
lated to conidial development showed various levels of
depression when A. flavus was treated with resveratrol
(Table 4). BrlA, AbaA, WetA, and StuA are pivotal
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regulators of conidiophore development and conidia
maturation; they act individually and together to regulate
their own expression and that of numerous other
sporulation-related genes. The transcriptomic profiling
showed that resveratrol significantly depressed the tran-
scriptional levels of stuA, fluG, flbC, and other genes re-
lated to conidial development. BrlA, a Cys2His2-type
conidiation transcription factor, mediates the develop-
mental switch from the apical growth pattern of vegeta-
tive cells to the budding growth of conidiophores; brlA
mutants cannot produce conidia [25]. The transcription
factor AbaA controls the temporal and spatial specificity
of development in Aspergillus. The expression of abaA
leads to the activation of brlA and wetA and to the ces-
sation of growth [82]. The regulatory protein WetA is
responsible for activating a set of genes whose products
make up the final two conidial wall layers or direct their
assembly [82]. The APSES transcription factor StuA
(stunted) is required for the orderly differentiation and
spatial organization of cell types of the conidiophores.
StuA affected the spatial localization of AbaA and BrlA,
and the expression of StuA is dependent on a functional
BrlA protein [46]. The transcript of GpaA/FadA was in-
volved in conidial development. A previous study dem-
onstrated that ΔgprA and ΔgprD mutants did not exhibit
hyper-conidiation when exposed to 0.5 and 1.0 mg fatty
acid-soaked discs [83]. The transcriptomic profiling
showed that resveratrol significantly depressed the tran-
scriptional levels of stuA, fluG, flbC, and other genes re-
lated to conidial development. These results demonstrated
that resveratrol greatly reduced conidia formation of A.
flavus by affecting gene expression at the transcriptomic
level.
Numerous studies indicated that conidial development
and secondary metabolism are co-regulated [84–87].
The heterotrimeric nuclear complex (VelB/VeA/LaeA
complex, Velvet complex) was demonstrated to be a glo-
bal regulator of fungal development and secondary me-
tabolism in Aspergillus [10, 84, 85, 88]. laeA and veA are
two critical genes in the formation of the Velvet com-
plex: VeA bridges VelB and LaeA to form the complex
[2, 88]. In our data, the transcription of laeA and veA
were slightly depressed in the A. flavus samples treated
with resveratrol (Table 4), which is consistent with the
results of previous studies. Microarray data provided evi-
dence for LaeA regulation of 24 clusters, including the
aflatoxin biosynthetic cluster, out of 55 secondary me-
tabolism clusters in A. flavus [87]. VeA regulates afla-
toxin, aflatrem, and cyclopiazonic acid production [1]. In
addition, null mutants of laeA and veA produced fewer
conidia and less aflatoxin in host seeds [2, 86]. This indi-
cated that the inhibition of laeA and veA transcript
levels by resveratrol may lead to a loss of toxin produc-
tion and conidia formation.
Conclusions
Resveratrol treatment of A. flavus decreased aflatoxin
production and conidia formation, and it also caused ab-
normal mycelia development. First, resveratrol directly
inhibited the expression of aflatoxin biosynthetic path-
way cluster genes, the aflA and aflB expression at sig-
nificantly low transcriptional levels could result in an
insufficient amount of the starter unit hexanoate for af-
latoxin biosynthesis. In addition, resveratrol could sig-
nificantly enhance the activity of antioxidative enzymes,
which destroy radicals produced within the cells that are
toxic to biological systems, leading to decreased afla-
toxin production. Second, the decreased transcription of
fluG and flbC could affect the mycelia (colony) develop-
ment and asexual sporulation. The altered appearance of
mycelia and mycelioid colonies could be a result of the
depressed transcription of the so-called fluffy gene
family. Third, resveratrol effectively decreased conidia
formation of A. flavus, which may result from the sup-
pressed transcription of genes related to conidial devel-
opment. The low level of transcription of stuA, brlA,
wetA, and abaA, the pivotal regulators of conidial devel-
opment and maturation, as well as other genes related
to conidial development, disrupted the cell’s orderly dif-
ferentiation and spatial organization of conidia, blocking
conidia formation. Fourth, the inhibition of laeA and
veA by resveratrol may lead to a loss of aflatoxin produc-
tion and conidia formation, which further demonstrated
that conidial development and secondary metabolism
are co-regulated.
Methods
Effects of resveratrol treatment on A. flavus
A toxigenic A. flavus strain (AF2202) isolated from pea-
nut was maintained at Oil Crops Research Institute of
Chinese Academy of Agricultural Sciences in glycerol
20 % at −80 °C. To prepare the A. flavus inoculum, some
conidia of AF2202 were taken from the stored sample
and cultured on fresh potato dextrose agar medium at
29 ± 1 °C for 7 days. Conidia were then collected and
suspended in sterile water containing 0.05 % Tween-80.
The concentration of conidia in the suspension was de-
termined using a haemocytometer.
Liquid A&M medium with a final resveratrol (Sigma®)
concentration of 3.0 μg/mL [12] was prepared and added
to conical 100-mL flasks containing 60 mL medium. Li-
quid A&M medium without resveratrol was used as a
control. Each flask was inoculated with 5 × 105 colony-
forming units (CFU) A. flavus conidia (freshly prepared).
The inoculated flasks were incubated at 30 °C with con-
tinuous shaking (160 rpm) for 3 or 7 days. After 3 days
of incubation, the fungal mycelia were collected by filtra-
tion and stored at −80 °C for RNA extraction. After
7 days of incubation, fungal mycelia were also collected
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by filtration, and the biomass was measured after drying
overnight at 60 °C. The dried mycelia were then ground
to fine powder and put back into the corresponding
flasks. Then, 25 mL chloroform was added to each flask
and incubated with continuous shaking (200 rpm) for
30 min at room temperature. Five milliliters of the
chloroform layer was added to a test tube and dried
under nitrogen gas. The residue was dissolved in 1.0 mL
methanol. Then, aflatoxins B1 and B2 were tested using
high-performance liquid chromatography as previously
described [12].
Solid A&M medium was prepared by adding agar to
the above liquid medium with or without resveratrol
(1.5 g agar was added to 100 mL liquid medium). The
solid medium was used to investigate the effect of res-
veratrol on conidia formation and mycelia growth of A.
flavus. A suspension with 1.6 × 105 conidia CFU was in-
oculated on a 90-mm diameter Petri dish containing
20 mL solid medium. The inoculated Petri dishes were
incubated at 30 °C in darkness for 7 days. For each dish,
the conidia were suspended, the concentration was de-
termined using a haemocytometer, and the colony diam-
eter was measured.
Three replications were performed for each treatment
in the above experiments.
RNA isolation and cDNA library construction
Aflatoxin was initially detected at 2 days of A. flavus
(AF2202) growth in liquid A&M medium. The aflatoxin
level increased at maximum rates between 3 and 4 days
and then increased slowly after that point. However, the
aflatoxin production rate in the resveratrol-treated cul-
ture (3.0 μg/mL) was much lower than that in the con-
trol when A. flavus was cultured between 3 and 4 days
(Additional file 8). Additionally, the conidia were initially
tested at 3 days of AF2202 growth on solid A&M
medium. The morphological changes of A. flavus sug-
gested that resveratrol could affect the expression of
genes that are related to aflatoxin production and co-
nidia formation. Therefore, we sampled the mycelium to
isolate RNA and constructed cDNA libraries when
AF2202 was cultured for 3 days.
Total RNA of AF2202 was isolated using the RNeasy®
Plant Mini Kit (QIAGEN) according to the manufac-
turer’s protocol. Each pooled RNA sample for cDNA li-
brary construction was composed of three individual
RNA samples with equal weight extracted from mycelia
that were independently cultured. All RNA samples were
treated with RNase-free DNase I. The concentration
and integrity of the pooled total RNA was checked
using a NanoDrop® 1000 spectrophotometer, a Qubit®
Fluorometer 2.0, and an Agilent 2100 bioanalyzer to
confirm that all samples had an RNA integrity num-
ber value above 9.0.
Sequencing libraries were constructed using the Illu-
mina TruSeq™ RNA Sample Preparation Kit (Illumina)
following the manufacturer’s instructions. Four index
codes were added to attribute sequences to each sample.
The mRNA was isolated from total RNA using poly-T
oligo-attached magnetic beads. Fragmentation was carried
out using divalent cations under elevated temperature in
Illumina proprietary fragmentation buffer. First-strand
cDNA was synthesized using random oligonucleotides
and SuperScript II. Second-strand cDNA synthesis was
subsequently performed using DNA polymerase I and
RNase H. Remaining overhangs were converted into blunt
ends via exonuclease/polymerase, and then enzymes were
inactivated. After adenylation of 3′ ends of cDNA frag-
ments, Illumina PE adapter oligonucleotides were ligated
for hybridization. The cDNA fragments of 200 bp in
length were isolated with the AMPure XP system (Beck-
man Coulter). DNA fragments with ligated adapter
molecules on both ends were selectively enriched using
Illumina PCR Primer Cocktail in a 15-cycle PCR. Products
were purified with the AMPure XP system and quantified
using the Agilient high-sensitivity DNA assay with the
Agilent Bioanalyzer 2100 system.
Clustering of the index-coded samples was performed
with a cBot Cluster Generation System using a TruSeq
PE Cluster Kit (v3-cBot-HS, Illumina) according to the
manufacturer’s instructions. After cluster generation, the
prepared libraries were sequenced with the Illumina
Hiseq 2000 platform, and then 100-bp paired-end reads
were generated.
Mapping reads to the reference genome and quantifying
gene expression
Raw data (raw reads) of fastq format were first processed
using in-house perl scripts. Clean data (clean reads) were
obtained by removing reads containing adapter, reads
containing poly-N, and low-quality reads from the raw
data. The Q20, Q30, GC content, and sequence duplica-
tion level of the clean data were calculated (Additional 1
and Fig. 3). All downstream analysis used the clean data
with high quality.
The A. flavus (NRRL 3357) genome and gene model an-
notation files were downloaded from the genome website
(ftp://ftp.ensemblgenomes.org/pub/release-17/fungi/fasta/
Aspergillus_flavus/dna/) directly. The index of the refer-
ence genome was built using Bowtie (v2.0.6) [89], and
paired-end clean reads were aligned to the reference gen-
ome using Tophat (v2.0.7) with “mismatch 2” as the
parameter [90]. HTSeq (v0.5.3p9) (http://www-huber.-
embl.de/users/anders/HTSeq) was used to count the read
numbers mapped to each gene. Then, the RPKM of each
gene was calculated based on the length of the gene and
read count mapped to this gene [29].
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Identification and analysis of DEGs
Prior to differential gene expression analysis, the read
counts for each sequenced library were adjusted using
the edgeR program package (TMM) with one scaling
normalization factor. Differential expression analysis of
two conditions (with and without resveratrol treatment)
was performed using DEGSeq (1.2.2) [91] and edgeR
(3.2.4) [92]. The p values were adjusted with the Benja-
mini and Hochberg method [93], and a corrected p
value (q value) of 0.005 and log2 (fold change) of 1
were set as the threshold for significantly differential
expression [94].
GO (http://www.geneontology.org/) is an international
standardized gene function classification system that of-
fers a dynamically updated, controlled vocabulary and
strictly defined concepts to comprehensively describe
properties of genes and their products in any organism.
In our experiments, GO enrichment analysis of DEGs
was implemented using GOseq (Release 2.12) [95], in
which the gene length bias was corrected. GO terms
with a corrected p value (q value) less than 0.05 were
considered to be significantly enriched by DEGs.
KEGG is the major public pathway-related database
[96] used to identify significantly enriched metabolic
pathways or signal transduction pathways in DEGs com-
pared to whole-genome background (http://www.geno-
me.jp/kegg/). We used KOBAS software (v 2.0) [97] to
test the statistical enrichment of DEGs in KEGG path-
ways. KEGG terms with a corrected p value (q value)
less than 0.05 were considered to be significantly
enriched in DEGs.
qRT-PCR analysis
To validate the repeatability and reproducibility of gene
expression data obtained by RNA-seq in A. flavus, we
randomly selected 16 DEGs for validation by qRT-PCR,
as described previously [13, 25, 98, 99]. Gene-specific
primer pairs (Table 2) were designed according to the
sequences of the 16 genes using the Primer 3-BLAST
program available online (bioinfo.ut.ee/primer3-0.4.0/
primer3/, NCBI). To ensure accuracy, each primer was
run with three replications on the same plate with a
negative control that lacked template cDNA to detect
non-specific products. For normalization, the A. flavus
18S rRNA gene was selected as the endogenous refer-
ence gene. The relative expression levels of genes were
calculated using the 2-ΔΔCt method [100, 101], which
represents the CT difference between the reference 18S
rRNA and the target gene products. Three replications
were performed for each qRT-PCR.
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